Is this you?
Request access for New York Gastroenterology Associates using your company work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
New York Gastroenterology Associates
Unclaimed profileIndependent Site · New York · ~1 sites
Intera lens
ICP 5Lift (cardio sample) 1.00Recruit soph 0
Quality Scorecard (1–100)
Overall65Recruit46Ops70Sponsor72Ther78
Performance (observed)
Historical trials
271
Completed
101
Terminated/Withdrawn
31
Completion rate
77%
Active now
132
Phase 2
104
Phase 3
148
Realized enrollment
247,714
First study year
2002
Years active
24
Match confidence
high
Enrollment velocity (inf)
10,321
Therapeutic
Areas
Cardiometabolic (cardiology/endocrinology/hepatology/renal, per ClinicalTrials.gov)
Breadth (conditions)
702
States
New York
Recruitment (web observed)
Capability notes
4 active recruiting cardiometabolic trials (ClinicalTrials.gov)
Relationships
Sponsors
National Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; SWOG Cancer Research Network; Gilead Sciences; Shire; Janssen Research & Development, LLC
CROs
Crohn's and Colitis Foundation; PPD, Part of Thermo Fisher Scientific; Premier Research; Teva Branded Pharmaceutical Products R&D LLC
Owner / parent
Unknown
Capacity & people
Investigators
—
Coordinators
—
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Surfaced via ClinicalTrials.gov mining (not on curated lists). 4 active recruiting cardiometabolic trials across 1 location(s). Actively-recruiting independent site = warm Intera lead; website/leadership not yet verified.
Recommendation features (sample indication)
Ind fit 1.00Liftability 1.00Overall65
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.